Longfellow Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.8K Hold
15
﹤0.01% 161
2025
Q4
$16.1K Hold
15
﹤0.01% 162
2025
Q3
$11.4K Buy
15
+6
+67% +$4.46K ﹤0.01% 180
2025
Q2
$7.02K Buy
9
+4
+80% +$3.11K ﹤0.01% 184
2025
Q1
$4.13K Hold
5
﹤0.01% 200
2024
Q4
$3.86K Hold
5
﹤0.01% 208
2024
Q3
$4.43K Hold
5
﹤0.01% 196
2024
Q2
$4.53K Hold
5
﹤0.01% 187
2024
Q1
$3.89K Hold
5
﹤0.01% 207
2023
Q4
$2.92K Hold
5
﹤0.01% 193
2023
Q3
$2.69K Hold
5
﹤0.01% 183
2023
Q2
$2.35K Hold
5
﹤0.01% 212
2023
Q1
$1.72K Hold
5
﹤0.01% 223
2022
Q4
$1.83K Sell
5
-8
-62% -$2.84K ﹤0.01% 225
2022
Q3
$4K Hold
13
﹤0.01% 259
2022
Q2
$5K Hold
13
﹤0.01% 268
2022
Q1
$4K Hold
13
﹤0.01% 306
2021
Q4
$4K Sell
13
-5
-28% -$1.27K ﹤0.01% 316
2021
Q3
$5K Hold
18
﹤0.01% 335
2021
Q2
$5K Sell
18
-8,480
-100% -$1.7M ﹤0.01% 350
2021
Q1
$1.59M Sell
8,498
-5,103
-38% -$998K 0.19% 131
2020
Q4
$2.3M Buy
+13,601
New +$2.03M 0.28% 87

Other funds holding LLY

Longfellow Investment Management's LLY Position: Q1 2026 in Review

Longfellow Investment Management held its Eli Lilly (LLY) position steady in Q1 2026 at 15 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #161.

Longfellow Investment Management first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.3M in Q4 2020. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Longfellow Investment Management held 15 shares of Eli Lilly worth $13.8K as of Q1 2026.
  • Longfellow Investment Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up ﹤0.01% of Longfellow Investment Management's portfolio in Q1 2026, its #161 holding.
  • Longfellow Investment Management first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Longfellow Investment Management's Eli Lilly position peaked at $2.3M in Q4 2020.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Longfellow Investment Management's 13F filing for Q1 2026, filed 12 May 2026.